相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Health-Related Quality of Life in Adrenocortical Carcinoma
Rebecca Steenaard et al.
CANCERS (2019)
Advanced Adrenocortical Carcinoma - What to do when First-Line Therapy Fails?
Felix Megerle et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2019)
Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy
Yuko Suzuki et al.
JOURNAL OF GASTROENTEROLOGY (2019)
Predictors of Survival in Adrenocortical Carcinoma: An Analysis From the National Cancer Database
Sri Harsha Tella et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer
Laura Mezquita et al.
JAMA ONCOLOGY (2018)
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors
Martin Fassnacht et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Gemcitabine-Based Chemotherapy in Adrenocortical Carcinoma: A Multicenter Study of Efficacy and Predictive Factors
Judith E. K. Henning et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
The neutrophil-to-lymphocyte ratio (NLR) predicts adrenocortical carcinoma and is correlated with the prognosis
Taku Mochizuki et al.
BMC UROLOGY (2017)
Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study
R. Libe et al.
ANNALS OF ONCOLOGY (2015)
Neutrophil-lymphocyte and platelet-lymphocyte ratio as predictors of disease specific survival after resection of adrenocortical carcinoma
Fabio Bagante et al.
JOURNAL OF SURGICAL ONCOLOGY (2015)
Management of adrenal cancer: a 2013 update
M. Terzolo et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2014)
Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review
Syed H. Jafri et al.
BMC CANCER (2013)
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
Martin Fassnacht et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study
Arti Hurria et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study
Paola Sperone et al.
ENDOCRINE-RELATED CANCER (2010)
Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma
Sebastian Wortmann et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Treatment of advanced Adrenocortical carcinoma with erlotinib plus gemcitabine
Marcus Quinkler et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Management of patients with adrenal cancer: recommendations of an international consensus conference
DE Schteingart et al.
ENDOCRINE-RELATED CANCER (2005)
Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer
SR Walsh et al.
JOURNAL OF SURGICAL ONCOLOGY (2005)
Use of a topoisomerase I inhibitor (irinotecan, CPT-11) in metastatic adrenocortical carcinoma
E Baudin et al.
ANNALS OF ONCOLOGY (2002)
分享论文
